Event snippet :

Aalto inside...


To play, press and hold the enter key. To stop, release the enter key.

​Aalto Bio Reagents

  • Founded in 1978

  • Market leader in the development of proteins and antibodies for new and emerging diseases eg. Chikungunya , Dengue , Zika , Sars , COVID-19 and VEEV virus

  • Custom manufacture of new recombinant antigens

  • Routine manufacture of bulk antigens and antibodies

  • Full raw material menu for chemiluminescence platforms

  • Europes largest provider of bulk disease state plasma for controls

Aalto's Latest News